First, an important note
This paper describes the plan for an upcoming trial.
No results yet. No winners yet.
What it offers is a careful blueprint for a study that could change how diabetes is treated in countries that don't always fit Western research models.
Why diabetes remission is suddenly possible
For decades, type 2 diabetes was treated like a one-way street. You got it, you managed it, and you lived with rising medication doses.
But newer research has flipped that thinking.
With enough weight loss — often 10 to 15 kilograms (22 to 33 pounds) — some people can push their blood sugar back into the normal range without diabetes medication. That's called remission.
Remission isn't a cure. It can fade if weight comes back. But it gives millions of people a real shot at fewer pills, fewer complications, and longer lives.
The two diet contenders
This trial pits two popular low-calorie eating plans against each other.
The Mediterranean diet is built around vegetables, fruits, beans, whole grains, olive oil, fish, and modest amounts of dairy and meat.
The low-carbohydrate diet cuts back on bread, rice, pasta, sugar, and starchy foods, leaning more on protein, healthy fats, and non-starchy vegetables.
Both can lead to weight loss. Both can improve blood sugar. But which one helps more people reach remission — and, more importantly, stick with it?
Why Lebanon matters for this question
Most diabetes remission research has come out of the UK, US, and parts of Europe.
That's a problem. Food culture shapes which diet you can actually follow for a year.
A diet plan that works in Glasgow may fall apart in Tripoli if it ignores local meals, family traditions, and food costs.
This trial is tailored to northern Lebanon — designed with the community, not just for it.
The behavior-science backbone
Here's what makes this study different. It uses a framework called Intervention Mapping (IM).
Think of IM as a detailed GPS for behavior change. Instead of handing someone a diet sheet and hoping for the best, researchers map out exactly which barriers to target — emotional, social, practical — and build the program around those.
That means stress eating, family meal pressures, budget limits, and cultural food habits all get addressed up front.
The plan calls for 50 adults, ages 18 to 65, across primary medical centers in northern Lebanon.
To join, participants must have had type 2 diabetes for six years or less and be treated with oral diabetes medications (not insulin yet).
They'll be randomly assigned to the low-calorie Mediterranean diet or the low-calorie low-carb diet.
The study runs for a full year — six months of active weight loss, followed by six months of maintenance supported by a mobile health app.
What "success" will look like
The primary outcome is diabetes remission at six months, measured by HbA1c — a blood test that reflects average blood sugar over about three months.
Researchers will also track weight, waist size, blood pressure, cholesterol, medication use, and quality of life.
This trial has not happened yet.
So we cannot say which diet will win. We can only say what the researchers will be watching for.
Why the maintenance phase is the real test
Lots of diets work for three months. Far fewer work for a year.
The second half of this study — the maintenance phase with a mobile app — is where real life tends to break diet plans.
Holidays. Family gatherings. Stress. Burnout.
By adding app-based support, the team is testing whether technology can carry people through the hardest part of behavior change.
Bigger remission trials like DiRECT in the UK have shown that structured, low-calorie diets can put nearly half of recently diagnosed patients into remission at one year.
Whether those results repeat in a Mediterranean cultural setting — with a different food environment, different medication access, and different support systems — is an open question.
This protocol is the kind of careful, local work that helps answer it.
If you have type 2 diabetes, this trial is not a treatment you can join unless you live in northern Lebanon and meet the criteria.
But the bigger message applies everywhere: remission may be possible for people with shorter-duration type 2 diabetes, especially when weight loss is structured and supported.
Talk with your doctor before changing diets, especially if you're on medications that can drop blood sugar too low.
Limitations to keep in mind
Fifty people is a small trial. Larger studies will be needed to confirm whatever this one finds.
The study is open-label — participants know which diet they're on — which can shape behavior.
And because it's set in one region, findings may not transfer directly to very different food cultures.
The trial is registered (ISRCTN99204002), which means results will eventually be public.
If the approach succeeds, it could become a model for designing culturally tailored diabetes programs in low- and middle-income countries — places where most of the world's diabetes actually lives.
